Our Venture Creation Strategies
De Novo
Building a company based on secular AI thesis and operationalizing it through our venture creation process.
Scientist-in-Residence
Partnering with leading researchers to productize, commercialize, and scale their ground-breaking discoveries.
Health System Asset Spin-out
Launching new businesses through spinning out and tech-enabling health system business units, to serve a broader market demand.
Asset Purchase
Acquiring companies with defensible IP data and GTM assets that can be leveraged to build new AI-enabled businesses.
1 / 4
Engagement with Digital Consortium Partners
Launch new companies together
- Identify shared problems and opportunities
- Build business plans and secure funding and customer commitments
- Form companies deal-by-deal as joint ventures
Create commercial Opportunities
- Leverage lighthouse accounts as early proofs of concept
- Understand common pain points across the rest of the Consortium
- Bring portfolio companies to other health systems
Convene the ecosystem
- Digital Consortium Leadership Retreat
- Dinners and networking receptions
- Hosted events at health systems
Systematic Value Creation
We co-develop with health systems at all stages of the company creation process. Our methodical, hands‑on approach to building businesses centers on phasing capital outlays around the attainment of technical, legal, and commercial value creation milestones. These milestones are tailored to isolate operational complexities, minimize downside exposure, and maximize asymmetric upside potential.